ESLAW vs. ATNFW, SXTPW, DRTSW, APLMW, BCDAW, BCTXW, CDIOW, CTCXW, SAVAW, and CELUW
Should you be buying Estrella Immunopharma stock or one of its competitors? The main competitors of Estrella Immunopharma include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.
Estrella Immunopharma (NASDAQ:ESLAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, community ranking, analyst recommendations, valuation, profitability, earnings, dividends and risk.
Estrella Immunopharma and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
In the previous week, Estrella Immunopharma and Estrella Immunopharma both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat Estrella Immunopharma's score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Summary
180 Life Sciences beats Estrella Immunopharma on 1 of the 1 factors compared between the two stocks.
Get Estrella Immunopharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESLAW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ESLAW vs. The Competition
Estrella Immunopharma Competitors List
Related Companies and Tools
Free ESLAW Stock Alerts